There is great interest in developing nanoparticle drug delivery systems for the delivery of
therapeutics or imaging agents for cancer. In this context, a new radiopharmaceutical was …

We hypothesized that a novel design of the LTVPWY (LY) peptide might exhibit a great
potential for improving binding affinity and targeting HER2-overexpressed tumors. Hence …

In the last two decades, science has largely evolved in methodologies for cancer treatment,
yet, the basic backbone of cancer treatment includes surgery, chemotherapy and radiation …

Summary Recently FDA-approved, 18 F-FES is a well-studied radiopharmaceutical with the
ability to provide molecular imaging of ER-positive breast cancer. In the setting of whole …

Early diagnosis of cancer is beneficial to improve the outcomes of clinical treatment and
reduce cancer mortality. Nanomaterials (NMs) have exhibited significant advantages in early …

A new strategy for the early diagnosis of triple-negative breast cancer (TNBC) is urgently
needed however specific targets are lacking. EphA2 has been reported to be over …

Transpathology is an emerging theory that transcends the limitations of multiscale
measurements in the characterization of pathophysiology for disease phenotyping …

In most malignancies, breast cancer is fatal, accounting for approximately 500,000 annual
deaths. The subtype of breast cancer known as Invasive Ductal Carcinoma (IDC) is …

Lung and colon cancers are responsible for a considerable number of deaths annually, with
lung cancer being the most prevalent and colon cancer following closely as the second most …

Purpose Anthracyclines have been one of the standard therapies for breast cancer (BC),
and dose-related cardiotoxicity is one serious side effect. Exercise is an effective strategy for …